Figure 10.
Comparison of the binding conformations of second-generation HCV NS3/4A protease inhibitors asunaprevir (A), danoprevir (B) and vaniprevir (C) with third generation inhibitor grazoprevir (D).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.